Yu Wei

568 total citations
15 papers, 402 citations indexed

About

Yu Wei is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yu Wei has authored 15 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Yu Wei's work include Platelet Disorders and Treatments (9 papers), Blood groups and transfusion (6 papers) and Blood properties and coagulation (2 papers). Yu Wei is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Blood groups and transfusion (6 papers) and Blood properties and coagulation (2 papers). Yu Wei collaborates with scholars based in China and Canada. Yu Wei's co-authors include Ming Hou, Jun Peng, Yawen Wang, Xuebin Ji, Xinguang Liu, Fang Zhou, Guoqiang Liu, Zhengcheng Wang, Jingxia Wang and Xuena Liu and has published in prestigious journals such as Blood, Scientific Reports and Acta Pharmacologica Sinica.

In The Last Decade

Yu Wei

15 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Wei China	7	316	85	74	72	39	15	402
Jihua Qiu China	14	314 1.0×	97 1.1×	114 1.5×	71 1.0×	18 0.5×	22	436
Ming Hou China	14	216 0.7×	35 0.4×	114 1.5×	93 1.3×	29 0.7×	31	461
Anna Baraldi Italy	9	88 0.3×	27 0.3×	24 0.3×	43 0.6×	26 0.7×	27	256
MJ Heeb United States	6	260 0.8×	19 0.2×	64 0.9×	136 1.9×	43 1.1×	8	347
Rafael Marino Canada	7	76 0.2×	46 0.5×	123 1.7×	142 2.0×	11 0.3×	11	369
Isabelle C. Becker United States	8	122 0.4×	8 0.1×	47 0.6×	30 0.4×	32 0.8×	24	221
Yusuke Shiozawa Japan	9	82 0.3×	56 0.7×	66 0.9×	48 0.7×	41 1.1×	19	258
Fumiaki Banno Japan	11	320 1.0×	8 0.1×	324 4.4×	104 1.4×	32 0.8×	21	536
JS Bennett United States	10	274 0.9×	20 0.2×	39 0.5×	25 0.3×	111 2.8×	14	434
György Temesszentandrási Hungary	8	113 0.4×	91 1.1×	76 1.0×	325 4.5×	8 0.2×	11	375

Countries citing papers authored by Yu Wei

Since Specialization

Citations

This map shows the geographic impact of Yu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wei more than expected).

Fields of papers citing papers by Yu Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wei. The network helps show where Yu Wei may publish in the future.

Co-authorship network of co-authors of Yu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Wei. A scholar is included among the top collaborators of Yu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Wei. Yu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wei, Yu, Mingming Sun, Ruili Zhang, et al.. (2025). Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. Acta Pharmacologica Sinica. 46(4). 1030–1044. 4 indexed citations

Shan, Wen, et al.. (2024). Chlorogenic Acid Mitigates Ferroptosis by Activating the Nrf2/GPX4 Pathway through Keap1 Blockade in Vascular Dementia Rats. Journal of Food Biochemistry. 2024(1). 1 indexed citations

Wei, Yu, et al.. (2024). HMGB1 inhibition blocks ferroptosis and oxidative stress to ameliorate sepsis‐induced acute lung injury by activating the Nrf2 pathway. The Kaohsiung Journal of Medical Sciences. 40(8). 710–721. 6 indexed citations

Qiu, Jihua, Xuena Liu, Xiaoqing Li, et al.. (2016). CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia. Scientific Reports. 6(1). 27445–27445. 74 indexed citations

Wei, Yu & Ming Hou. (2016). T cells in the pathogenesis of immune thrombocytopenia. Seminars in Hematology. 53. S13–S15. 24 indexed citations

Xu, Jianping, et al.. (2016). [Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement--3 000 Cases Follow-up].. PubMed. 47(1). 90–2. 4 indexed citations

Fu, Lingling, et al.. (2016). [Clinical study of pulsed high- dose dexamethasone treatment in 38 children with primary immune thrombocytopenic purpura].. PubMed. 37(10). 912–915. 6 indexed citations

Hou, Yu, Qi Feng, Miao Xu, et al.. (2016). High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia. Blood. 127(12). 1587–1597. 49 indexed citations

Liu, Xinguang, Shuang Liu, Qi Feng, et al.. (2016). Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP. Blood. 128(6). 852–861. 58 indexed citations

10.

Wei, Yu, Xuebin Ji, Yawen Wang, et al.. (2015). High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 127(3). 296–302. 145 indexed citations

11.

Qin, Ping, Yu Wei, Ming Hou, Chunting Zhao, & Zhixiang Shen. (2015). [A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients].. PubMed. 36(2). 103–6. 16 indexed citations

12.

Wei, Yu, Xuebin Ji, Jingxia Wang, et al.. (2014). Conventional Oral Prednisone Versus High-Dose Dexamethasone for Management of Adult Immune Thrombocytopenia: A Prospective Randomized Multicenter Clinical Trial. Blood. 124(21). 1455–1455. 2 indexed citations

13.

Cui, Zhongguang, Yu Wei, Ming Hou, Hongguo Zhao, & Hongyi Wang. (2011). [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].. PubMed. 50(5). 401–3. 4 indexed citations

14.

Zhang, Chunxiao, et al.. (2011). Validation of four different risk stratification models in patients undergoing heart valve surgery in a single center in China.. PubMed. 124(15). 2254–9. 5 indexed citations

15.

Hu, Dayi, et al.. (2003). Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study.. PubMed. 116(6). 853–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact